5-Chloro-3,3,7-trimethyl-2,3-dihydro-1h-indol-2-one

Catalog No.: 
ACAONR095
CAS No.: 
1511510-26-1
Molecular Formula: 
C11H12ClNO
Molecular Weight: 
209.68
5-Chloro-3,3,7-trimethyl-2,3-dihydro-1h-indol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$331.00InquiryInquiry
1g95%$958.00InquiryInquiry
5g95%$4742.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-3,3,7-trimethyl-2,3-dihydro-1h-indol-2-one
IUPAC Name5-chloro-3,3,7-trimethylindolin-2-one
MDL No.MFCD23921673
Molecular FormulaC11H12ClNO
Molecular Weight209.68
SMILESO=C1NC2=C(C=C(Cl)C=C2C)C1(C)C
InChI KeyKHEPIMSKPYPWMK-UHFFFAOYSA-N
Synonym2H-Indol-2-one, 5-chloro-1,3-dihydro-3,3,7-trimethyl-
CAS No.1511510-26-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAONR095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAONR095 route product structure diagram
    ACAONR0951511510-26-1
Inquiry

2. ACAONR095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAONR095 route product structure diagram
    ACAONR0951511510-26-1
Inquiry

3. ACAONR095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAONR095 route product structure diagram
    ACAONR0951511510-26-1
Inquiry

Comments (0)